Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System

Poster Reprint ASMS 2023 Poster number TP 732 Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System Bertram Lee1, Linfeng Wu1, Shan-An Chan2 and Winnie Huang3 1Agilent Technologies, Inc., Santa Clara, CA,…

Application Note Determination of Nitrosamine Impurities Using the Agilent 6495D Triple Quadrupole LC/MS System Authors Abstract Lee Bertram and Linfeng Wu Agilent Technologies, Inc. Nitrosamine impurities are byproducts produced in trace amounts during the manufacture of pharmaceutical drugs. These impurities…

Application Note Biopharma Quantitative Analysis of Nitrosamine Impurities in Synthetic Oligonucleotides Using the Agilent 6495D triple quadrupole LC/MS system Author Abstract Yulan Bian Agilent Technologies, Inc. Nitrosamines are genotoxic impurities of significant concern in pharmaceuticals due to their carcinogenic potential.…

Application note | 003215 Pharma Highly sensitive method for the determination of 12 nitrosamine impurities in multiple ARBs, the class of sartan drug formulations Application benefits Authors Varun Khali , Manoj Kushwaha , Dr. Sachin 1 1 • Single method…